Medical Research News

Nursing

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Jannini EA et al. - An overall equivalence was demonstrated in the subjective perception of treatment benefits for all the PDE5i tested. However, sildenafil, in a dose-dependent manner, was the unique PDE5i able to ameliorate some of the penile flow parameters within the 8-week treatment period. These findings should be interpreted conservatively because of the observational nature of the study.

Related Articles

Hormonal Testing and Pharmacologic Treatment of Erectile Dysfunction: A Clinical Practice Guideline From the American College of Physicians
Annals of Internal Medicine, 10/30/09    Relevance Score: 70%

Effects of 12-Month Tadalafil Therapy for Erectile Dysfunction on Couple Relationships: Results from the DETECT Study
The Journal of Sexual Medicine, 10/28/09    Relevance Score: 69%

Evaluation of Microalbuminuria in Patients with Erectile Dysfunction
The Journal of Sexual Medicine, 10/07/09    Relevance Score: 69%

New Drug Udenafil for Erectile Dysfunction in US Trials
Internet Source, 11/10/09    Relevance Score: 68%

The Association of Serum Prolidase Activity and Erectile Dysfunction
Journal of Andrology, 10/23/09    Relevance Score: 68%

Today in Clinical Pharmacology...keeping you current

Divalproex Sodium-Induced Eosinophilic Pleural Effusion
American Journal of Therapeutics, 12/04/09

Lithium and thyroid
Best Practice & Research Clinical Endocrinology & Metabolism, 12/04/09

Acute Generalized Exanthematous Pustulosis: A Rare Clinical Entity With Use of Piperacillin/Tazobactam
American Journal of Therapeutics, 12/04/09

Today in Nephrology/Urology...keeping you current

Fever and chills in a toddler having frequent wetting episodes
The Clinical Advisor, 12/04/09

Vasculitis
Journal of Allergy and Clinical Immunology, 12/04/09

Endothelial dysfunction and erectile dysfunction in the aging man
International Journal of Urology, 12/04/09